Ruplizumab (Anti-TNFSF5 / CD40L / CD154), 1mg*25

Ruplizumab (Anti-TNFSF5 / CD40L / CD154), 1mg*25

Vilobelimab (Anti-Complement C5), 1mg*5

Vilobelimab (Anti-Complement C5), 1mg*5

Vilobelimab (Anti-Complement C5), 1mg

3.700,90 RON
SKU
SKM_A3101_1mg

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Mai multe informatii
Price 3.110,00 RON (preturile sunt fara TVA)
Description

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.